Gaush Meditech Ltd. (HK:2407) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Gaush Meditech Ltd has reported a significant downturn in its financial performance for the first half of 2024, with revenues dipping to RMB642.0 million, an 8.4% decrease from the previous year, and net profits plummeting by 75.6% to RMB26.9 million. Despite this, the company increased its research and development spending by 34.5%, indicating a continued focus on innovation. No interim dividend will be paid, similar to the previous year.
For further insights into HK:2407 stock, check out TipRanks’ Stock Analysis page.